首页> 中国专利> 一种治疗肺部症状为首发表现的韦格纳肉芽肿病的中药组合物及其制备方法

一种治疗肺部症状为首发表现的韦格纳肉芽肿病的中药组合物及其制备方法

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明属于医药技术领域，具体涉及一种治疗肺部症状为首发表现的韦格纳肉芽肿病的中药组合物及其制备方法。本该中药组合物由如下重量份的中药原料药组成：白花苋80-120份、毛诃子40-60份、白发蛇舌草130-170份、古山龙130-170份、挂金灯16-24份、光头前胡40-60份。该药物用于治疗肺部症状为首发表现的韦格纳肉芽肿病，总有效率高达88.57%。

著录项

公开/公告号CN105168562A

专利类型发明专利
公开/公告日2015-12-23

原文格式PDF
申请/专利权人济南新时代医药科技有限公司;
展开▼

申请/专利号CN201510699291.2
发明设计人刘爱良;
展开▼

申请日2015-10-26
分类号A61K36/81;A61P9/14;
代理机构
代理人
地址 250200 山东省济南市章丘市唐人中心A5-125号
入库时间 2023-12-18 13:04:21

法律信息

法律状态公告日

法律状态信息

法律状态
2019-04-23

发明专利申请公布后的撤回 IPC(主分类):A61K36/81 申请公布日:20151223 申请日:20151026

发明专利申请公布后的撤回
2016-01-20

实质审查的生效 IPC(主分类):A61K36/81 申请日:20151026

实质审查的生效
2015-12-23

公开

公开

相似文献

专利
中文文献
外文文献

1. 一种治疗肺部症状为首发表现的韦格纳肉芽肿病的中药组合物及其制备方法 [P] . 中国专利： CN105168562A . 2015-12-23
2. 一种治疗肺部症状为首发表现的韦格纳肉芽肿病的药物及其制备方法 [P] . 中国专利： CN103919913A . 2014-07-16
3. Method of inhibiting the occurrence of one or more of the following conditions: monocyte / macrophage proliferation; or the proliferation of smooth muscle cells; or the expression of cd36 receptors; or the absorption of low-density lipoprotein - oxidized ldl, method of relief of symptoms of treatment or prevention of atherosclerosis; diabetes; alzheimer's disease, method of inhibiting the occurrence of plaque formation in the vascular system, method of relieving inflammation associated with the occurrence of one or more of the following conditions: the proliferation of monocytes, the proliferation of smooth muscle cells, the expression oxidized ldl or decontaminating receptor, pharmaceutical composition, use of an effective amount of one or more derivatives or phosphate of one or more electron transfer agents together with a suitable vehicle or diluent, use of an effective amount of one or more (alpha) -tocopherol phosphate derivatives together with an appropriate vehicle or diluent an [P] . BRPI0406484A . 2005-12-06

机译：抑制下列一种或多种状况发生的方法：单核细胞/巨噬细胞增殖;或平滑肌细胞的增殖;或cd36受体的表达;或低密度脂蛋白-氧化低密度脂蛋白的吸收，缓解或治疗动脉粥样硬化症状的方法;糖尿病;阿尔茨海默氏病，抑制血管系统中斑块形成的方法，缓解与以下一种或多种状况有关的炎症的方法：单核细胞的增殖，平滑肌细胞的增殖，氧化的ldl或去污受体，药物组合物，有效量的一种或多种衍生物或一种或多种电子转移剂的磷酸盐与合适的媒介物或稀释剂一起使用，有效量的一种或多种α-生育酚磷酸酯衍生物一起使用用适当的媒介物或稀释剂
4. compound of formula i; pharmaceutical composition; method of treating disorders that are related to or affected by inhibition of norepinephrine reuptake, the 5-ht6 receptor or the 5-ht2a receptor; a method of treating a learning disorder, a cognitive disorder, a memory disorder, a personality disorder, a behavioral disorder, a movement disorder, a neurodegenerative disorder, drug withdrawal disorder, sleep, an eating disorder, acute drug toxicity, a cardiovascular disorder, a sexual dysfunction, a gastrointestinal disorder, a genitourinary disorder, a pain disorder, a nervous disorder or a symptom disorder vasomotor; method of treating alzheimer's disease, attention deficit disorder, schizophrenia, parkinson's disease, tardive dyskinesia, ataxia, bradykinesia, paroxysmal dyskinesias, restless leg syndrome, tremor, essential tremor epilepsy, stroke or head trauma; method of treating coronary artery disease, myocardial infarction, transient ischemic attack, angina, atrial fibrillation, p [P] . BRPI0706523A2 . 2011-01-04

机译：式I化合物;药物组合物;治疗与去甲肾上腺素再摄取，5-ht6受体或5-ht2a受体相关或受其抑制的疾病的方法;一种治疗学习障碍，认知障碍，记忆障碍，人格障碍，行为障碍，运动障碍，神经退行性疾病，戒断药物，睡眠，进食障碍，急性药物毒性，心血管疾病的方法，性功能障碍，胃肠道疾病，泌尿生殖系统疾病，疼痛疾病，神经疾病或症状-血管舒缩;治疗阿尔茨海默氏病，注意力缺陷障碍，精神分裂症，帕金森氏病，迟发性运动障碍，共济失调，运动迟缓，阵发性运动障碍，不安腿综合征，震颤，原发性震颤癫痫，中风或头部外伤的方法;治疗冠状动脉疾病，心肌梗塞，短暂性脑缺血发作，心绞痛，心房颤动，p的方法
5. Compound, pharmaceutical compositions, process for treating depression, anxiety, psychosis, parkinson's disease, obesity, hypertension, tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, alzheimer's disease, senile dementia, obsessive-compulsive behavior , panic attacks, eating ailments, anorexia, cardiovascular and cerebrovascular disorders, migraine, non-insulin dependent diabetes mellitus, hyperglycemia, constipation, arrhythmia, disorders of the neuroendocrine system, tension, prostatic hypertrophy, extrapyramidal symptoms induced by drugs or spasticity, use of a compound, and, process for preparing the compound [P] . BR9910927A . 2001-02-20

机译：化合物，药物组合物，治疗抑郁症，焦虑症，精神病，帕金森氏病，肥胖症，高血压，抽动秽语综合征，性功能障碍，吸毒成瘾，药物滥用，认知障碍，阿尔茨海默氏病，老年性痴呆，强迫症，惊恐发作，饮食疾病，厌食症，心脑血管疾病，偏头痛，非胰岛素依赖型糖尿病，高血糖，便秘，心律不齐，神经内分泌系统疾病，紧张，前列腺肥大，药物或痉挛引起的锥体外系症状，使用化合物以及，化合物的制备方法